Skip to main content

239 Efficacy and toxicity of single agent immune checkpoint inhibitors among adults with cancer aged ≥80 years: a multicenter international cohort study

Publication ,  Conference
Nebhan, C; Cortellini, A; Ma, W; Ganta, T; Song, H; Ye, F; Irlmeier, R; Debnath, N; Saeed, A; Radford, M; Alahmadi, A; Diamond, A; Hoimes, C ...
Published in: Regular and Young Investigator Award Abstracts
November 2021

Duke Scholars

Published In

Regular and Young Investigator Award Abstracts

DOI

Publication Date

November 2021

Start / End Page

A257 / A257

Publisher

BMJ Publishing Group Ltd

Conference Name

SITC 36th Anniversary Annual Meeting (SITC 2021) Abstracts

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3204 Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Nebhan, C., Cortellini, A., Ma, W., Ganta, T., Song, H., Ye, F., … Naqash, A. R. (2021). 239 Efficacy and toxicity of single agent immune checkpoint inhibitors among adults with cancer aged ≥80 years: a multicenter international cohort study. In Regular and Young Investigator Award Abstracts (pp. A257–A257). BMJ Publishing Group Ltd. https://doi.org/10.1136/jitc-2021-sitc2021.239
Nebhan, Caroline, Alessio Cortellini, Weijie Ma, Teja Ganta, Haocan Song, Fei Ye, Rebecca Irlmeier, et al. “239 Efficacy and toxicity of single agent immune checkpoint inhibitors among adults with cancer aged ≥80 years: a multicenter international cohort study.” In Regular and Young Investigator Award Abstracts, A257–A257. BMJ Publishing Group Ltd, 2021. https://doi.org/10.1136/jitc-2021-sitc2021.239.
Nebhan C, Cortellini A, Ma W, Ganta T, Song H, Ye F, et al. 239 Efficacy and toxicity of single agent immune checkpoint inhibitors among adults with cancer aged ≥80 years: a multicenter international cohort study. In: Regular and Young Investigator Award Abstracts. BMJ Publishing Group Ltd; 2021. p. A257–A257.
Nebhan, Caroline, et al. “239 Efficacy and toxicity of single agent immune checkpoint inhibitors among adults with cancer aged ≥80 years: a multicenter international cohort study.” Regular and Young Investigator Award Abstracts, BMJ Publishing Group Ltd, 2021, pp. A257–A257. Crossref, doi:10.1136/jitc-2021-sitc2021.239.
Nebhan C, Cortellini A, Ma W, Ganta T, Song H, Ye F, Irlmeier R, Debnath N, Saeed A, Radford M, Alahmadi A, Diamond A, Hoimes C, Ramaiya N, Presley C, Owen D, Alaiwi SA, Nassar A, Ricciuti B, Lamberti G, Bersanelli M, Casartelli C, Buti S, Marchetti P, Giusti R, Filetti M, Vanella V, Mallardo D, Macherla S, Sussman T, Botticelli A, Galetta D, Catino A, Pizzutilo P, Genova C, Bello MGD, Kalofonou F, Daniels E, Ascierto P, Pinato D, Choueiri T, Johnson D, Marron T, Wang Y, Naqash AR. 239 Efficacy and toxicity of single agent immune checkpoint inhibitors among adults with cancer aged ≥80 years: a multicenter international cohort study. Regular and Young Investigator Award Abstracts. BMJ Publishing Group Ltd; 2021. p. A257–A257.

Published In

Regular and Young Investigator Award Abstracts

DOI

Publication Date

November 2021

Start / End Page

A257 / A257

Publisher

BMJ Publishing Group Ltd

Conference Name

SITC 36th Anniversary Annual Meeting (SITC 2021) Abstracts

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3204 Immunology